设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
CNKI学位论文(275)
CNKI期刊论文0611(1)
知网期刊论文(691)
在“
Elsevier电子期刊
”中,
命中:
223
条,耗时:0.0279861 秒
在所有数据库中总计命中:
967
条
1.
Receptor Tyrosine
Kinase
s: Translocation Partners in Hematopoietic Disorders
作者:
Katelyn N. Nelson
1
;
Malalage N. Peiris
1
;
April N. Meyer
1
;
Asma Siari
2
;
Daniel J. Donoghue
1
;
3
;
ddonoghue@ucsd.edu
关键词:
leukemia
;
lymphoma
;
oncogenic fusion
;
ALK
;
FGFR
;
PDGFR.
刊名:Trends in Molecular Medicine
出版年:2017
2.
Genetic inhibition of
Anaplastic
Lymphoma
Kinase
rescues cognitive impairments in Neurofibromatosis 1 mutant mice
作者:
Joseph B. Weiss
a
;
Sydney J. Weber
b
;
Eileen Ruth S. Torres
b
;
Tessa Marzulla
b
;
Jacob Raber
b
;
c
;
raberj@ohsu.edu
关键词:
Alk
;
NF1
;
Hippocampus
;
Cognition
;
Neurofibromatosis
刊名:Behavioural Brain Research
出版年:2017
3.
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R
作者:
Gangadhar Rao Mathi
a
;
b
;
Chung Hyo Kang
a
;
c
;
Heung Kyoung Lee
a
;
Raghavendra Achary
a
;
b
;
Ha-Yeon Lee
a
;
d
;
Joo-Youn Lee
e
;
Jae Du Ha
a
;
Sunjoo Ahn
a
;
b
;
Chi Hoon Park
a
;
b
;
Chong Ock Lee
a
;
Jong Yeon Hwang
a
;
b
;
Chang-Soo Yun
a
;
b
;
Hee Jung Jung
a
;
b
;
Sung Yun Cho
a
;
b
;
Hyoung Rae Kim
a
;
hyungrk@krict.re.kr
;
Pilho Kim
a
;
b
;
pkim@krict.re.kr
关键词:
Anaplastic
lymphoma
kinase
(
ALK
)
;
Non-small cell lung cancer (NSCLC)
;
Ceritinib
;
Crizotinib-resistant
;
G1202R
刊名:European Journal of Medicinal Chemistry
出版年:2017
4.
The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable
作者:
Thanyanan Reungwetwattana
a
;
Ying Liang
b
;
Viola Zhu
c
;
d
;
Sai-Hong Ignatius Ou
d
;
ignatius.ou@uci.edu
关键词:
ALK
;
anaplastic
lymphoma
kinase
;
CNS
;
central nervous system
;
EGFR
;
epidermal growth factor receptor
;
FDA
;
food and drug administration
;
GCN
;
gene copy number
;
HGF
;
hepatocyte growth factor
;
IC50
;
half inhibitory concentration
;
IHC
;
immunohistochemistry
;
mAb
;
monoclonal antibody
;
METex14
;
MET exon 14
;
METex14+ NSCLC
;
METex14 altered NSCLC
;
NSCLC
;
non-small cell lung cancer
;
ORR
;
overall response rate
;
PD-1
;
programmed cell death protein 1
;
RTK
;
receptor tyrosine
kinase
;
SqCC
;
squamous cell carci
刊名:Lung Cancer
出版年:2017
5.
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America
作者:
Luis E. Raez
1
;
2
;
lraez@mhs.net
;
Edgardo S. Santos
3
;
Christian Rolfo
4
;
Gilberto Lopes
5
;
Carlos Barrios
6
;
Andres Cardona
7
;
Luis A. Mas
8
;
Oscar Arrieta
9
;
Eduardo Richardet
10
;
Carlos Vallejos S
11
;
Ignacio Wistuba
12
;
David Gandara
13
;
Fred R. Hirsch
14
关键词:
ALK
;
EGFR
;
Molecular markers
;
Screening
;
Targeted therapy
刊名:Clinical Lung Cancer
出版年:2017
6.
CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin
Lymphoma
Cells
作者:
Mariko Watanabe
&lowast
;
;
Kazumi Nakano
&dagger
;
;
Marshall E. Kadin
&Dagger
;
;
Masaaki Higashihara
&lowast
;
;
Toshiki Watanabe
&dagger
;
;
Ryouichi Horie
&lowast
;
;
§
;
;
rhorie@med.kitasato-u.ac.jp
刊名:The American Journal of Pathology
出版年:2017
7.
Anaplastic
Lymphoma
Kinase
-Negative Anaplastic Large Cell Lymphoma Manifesting as a Scalp Hematoma After an Acute Head Injury—a Case Report and Literature Review
作者:
Chi-Yung Yeung
1
;
Kun-Ting Hong
2
;
Chien-Ping Chiang
3
;
Yuan-Hao Chen
2
;
Hsin-I Ma
2
;
Tung-Hang Tsai
2
;
tunghantsai269@gmail.com" class="auth_mail" title="E-mail the corresponding author
关键词:
Anaplastic
large cell
lymphoma
(ALCL)
;
Anaplastic
lymphoma
kinase
(
ALK
)
;
Head injury
;
Scalp hematoma
刊名:World Neurosurgery
出版年:2016
8.
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent
anaplastic
lymphoma
kinase
(
ALK
) inhibitors
作者:
Peilong Zhang
a
;
c
;
Jiaqiang Dong
b
;
djiaqiang@163.com" class="auth_mail" title="E-mail the corresponding author
;
Boyu Zhong
b
;
Deyi Zhang
b
;
Hongbin Yuan
b
;
Can Jin
b
;
Xiangyuan Xu
b
;
Hailong Li
b
;
Yong Zhou
b
;
Zhi Liang
b
;
Minghua Ji
b
;
Tao Xu
b
;
Guowei Song
b
;
Ling Zhang
b
;
Gang Chen
b
;
Xuejing Meng
b
;
Desheng Sun
b
;
Joe Shih
b
;
Ruihao Zhang
b
;
Guojun Hou
b
;
Chengcheng Wang
b
;
Ying Jin
b
;
Qiong Yang
b
关键词:
ALK
;
Kinase
;
Anti-tumor
;
NSCLC
;
Pyrimidine
刊名:Bioorganic & Medicinal Chemistry Letters
出版年:2016
9.
A novel acquired
ALK
F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib
作者:
Sandeep Kodityal
a
;
Julia A. Elvin
b
;
Rachel Squillace
b
;
Nikita Agarwal
b
;
Vincent A. Miller
b
;
Siraj M. Ali
b
;
Samuel J. Klempner
c
;
Sai-Hong Ignatius Ou
c
;
ignatius.ou@uci.edu" class="auth_mail" title="E-mail the corresponding author
关键词:
Crizotinib
;
Ceritinib
;
ALK
F1245C
;
Acquired
anaplastic
lymphoma
kinase
resistance mutation
;
Comprehensive genomic profiling
;
ALK
-positive NSCLC
;
Next generation sequencing
刊名:Lung Cancer
出版年:2016
10.
Novel 2,4-diaminopyrimidines bearing tetrahydronaphthalenyl moiety against
anaplastic
lymphoma
kinase
(
ALK
): Synthesis, in vitro, ex vivo, and in vivo efficacy studies
作者:
Dawn Song
a
;
Minji Lee
b
;
Chi Hoon Park
c
;
d
;
Sunjoo Ahn
c
;
d
;
Chang Soo Yun
c
;
d
;
Chong Ock Lee
c
;
Hyoung Rae Kim
c
;
hyngrk@krict.re.kr" class="auth_mail" title="E-mail the corresponding author
;
Jong Yeon Hwang
c
;
d
;
jyhwang@krict.re.kr" class="auth_mail" title="E-mail the corresponding author
关键词:
Anaplastic
lymphoma
kinase
;
Cancer
;
2
;
4-Diaminopyrimidine
;
Tetrahydronaphthalenyl
刊名:Bioorganic & Medicinal Chemistry Letters
出版年:2016
1
2
3
4
5
6
7
8
9
按检索点细分(223)
题名(29)
关键词(58)
文摘(143)
按出版年细分(223)
2027年及以后(28)
2017年(6)
2016年(30)
2015年(9)
2013年(29)
2012年(27)
2011年(18)
2010年(16)
2009年(7)
2008年(6)
2007年(10)
2006年(7)
2005年(6)
2004年(8)
2003年(5)
2001年(2)
2000年(2)
2000年及以前(7)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.